An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons

Xenotransplantation

Volumn 10, Issue 1, 2003, Pages 80-87

  Gollackner, B ^a   Ryan, D ^b   Knosalla, C ^a   Basker, M ^a   Alwayn, I P J ^a   Harper, D ^c   Salomon, G ^b   Mauiyyedi, S ^a   Correa, L ^b   Thall, A ^c,d   Cooper, D K C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Immerge Biotherapeutics Inc   (United States)

^c BioTransplant Inc   (United States)

^d BIOGEN   (United States)

Author keywords

Anti Gal antibodies; Arsenic trioxide; B cells; Baboons; Plasma cells; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE ANTIBODY; ANTIBODY; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CD20 ANTIGEN; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RITUXIMAB; UNCLASSIFIED DRUG; ARSENIC; DISACCHARIDE; GALACTOSYL (1 3)GALACTOSE; GALACTOSYL-(1-3)GALACTOSE; MONOCLONAL ANTIBODY; ORGANOARSENIC DERIVATIVE; OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; AUTOPSY; B LYMPHOCYTE; BABOON; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MALE; NONHUMAN; PEYER PATCH; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; TONSIL; WHOLE BODY RADIATION; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; BONE MARROW CELL; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; PAPIO; SPLEEN; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; ARSENIC; ARSENICALS; BONE MARROW CELLS; DISACCHARIDES; LYMPH NODES; OXIDES; PAPIO; PLASMA CELLS; SPLEEN; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0037997321     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2003.01136.x     Document Type: Conference Paper

References (16)

1. ALWAYN IPJ, BASKER M, BUHLER L, COOPER DKC. The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999; 6: 157.
2. GOOD AH, COOPER DKC, MALCOLM AJ et al. Identification of carbohydrate structures that bind human anti-porcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
3. ORIOL R, YE Y, KOREN E et al. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
4. COOPER DKC, CAIRNS TDH, TAUBE DH. Extracorporeal immunoadsorption of anti-pig antibody in pigs using αGal oligosaccharide immunoaffinity columns. Xeno 1996; 4: 27.
5. Xu Y, LORF T, SABLINSKI T et al. Removal of anti-porcine natural antibodies from human and non-human primate plasma in vitro and in vivo by a Galα1-3Galβ1-4Glc-X immunoaffinity column. Transplantation 1998; 65: 172.
6. ALWAYN IPJ, XU X, BASKER M et al. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-αGal antibody. Xenotransplantation 2001; 8: 157.
7. ROUSSELOT P, LABAUME S, MAROLLEAU JP et al. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 1999; 59: 1041.
8. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89: 3354.
9. WATTS A, FOLEY A, AWWAD M et al. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Galantibody: experience with 320 aphereses in baboons. Xenotransplantation 2000; 3: 181.
10. QUATREHOMME G, RICO O, LAPALUS P, JACOMET Y, OLLIER A. Acute arsenic intoxication: forensic and toxicologic aspects (an observation). J Forensic Sci 1992; 37: 1163.
11. HUANG CH, CHEN WJ, WU CC, CHEN YC, LEE YT. Complete atrioventricular block after arsenic trioxide treatment in an acute promyelocytic leukemic patient. Pacing Clin Electrophysiol 1999; 22: 965.
12. POKLIS A, SANDY JJ. Arsenic poisoning: acute or chronic? Suicide or murder? Am J Forensic Med Pathol 1990; 11: 226.
13. PASTAN I, FITZGERALD D. Recombinant toxins for cancer treatment. Science 1991; 254: 1173.
14. DEWEY WC, LING CC, MEYN RE. Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33: 781.
15. SAUSVILLE EA, HEADLEE D, STETLER-STEVENSON M et al. Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study. Blood 1995; 85: 3457.
16. FLAVELL DJ, NOSS A, PULFORD KAF et al. Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice. Cancer Res 1997; 57: 4824.